Strategic Partnerships Leverage Cortechs.ai’s recent partnerships with Siemens Healthineers, Philips, Viz.ai, and ARJ Medical to position joint value propositions around AI-powered neuroimaging workflows and scalable deployment across large hospital networks.

Clinical Integration Target health systems and imaging groups already using NeuroQuant or similar quantitative MRI tools for brain atrophy assessment, emphasizing seamless integration with Microsoft PowerScribe One and other enterprise reporting solutions to enable AI at scale.

Geographic Expansion Capitalize on Middle East and GCC market entry via ARJ Medical, alongside global distribution through Siemens and Philips, to pursue multi-region contracts and localized implementations in neurology and oncology imaging.

Healthcare Value Highlight NeuroQuant as FDA-cleared and CE-marked, offering automated, quantitative brain atrophy analysis that can support early diagnosis in neurodegenerative diseases and improve treatment planning in oncology imaging workflows.

Growth Readiness With 51-200 employees and revenue in the tens of millions, emphasize capacity to scale via strategic partnerships, expanding into additional markets, and integrating with existing hospital IT ecosystems to drive broader adoption of AI-powered imaging.